David Markowitz, Program Manager of the Intelligence Advanced Research Projects Activity (IARPA) David A. Markowitz, PhD is a Program Manager at the Intelligence Advanced Research Projects Activity (IARPA), the high-risk, high-reward research arm of the United States Intelligence Community. Dr. Markowitz runs programs at the interface between biology and engineering, including the [...]
Meagan Lizarazo, VP and COO of iGEM Foundation Meagan Lizarazo is Vice President and Chief Operating Officer of the iGEM Foundation. She leads iGEM’s expansion and strategic global initiatives as well as directing the new After iGEM program. The iGEM Foundation is an independent nonprofit dedicated to education, competition, the advancement of synthetic biology, and the development of open community and collaboration. iGEM fosters scientific research and education [...]
Philip Hemme, CEO of Labiotech.eu Philip Hemme, a young French-German entrepreneur, is the co-founder & CEO of Labiotech.eu, Europe’s biggest digital media platform for biotech. The company was founded in Berlin in September 2014, five days after he graduated from Boston University and Sup’Biotech. Philip has been invited to come onto the stage [...]
Amy Chen, Student at University of Calgary Amy Chen is currently a Bachelor of Health Sciences student at the University of Calgary. Her interest in the integration of biology research and innovative technologies has led her to participate in the International Genetically Engineered Machines Competition as a member of the 2017 UCalgary [...]
Gabriel Lopez, CEO of Synvivia Gabriel Lopez is founder and CEO of Synvivia, a startup developing genetically encoded biocontainment technology for engineered organisms. Synvivia’s genetically programmable framework offers intrinsic biosafety and biosecurity. With Synvivia’s technology, engineered organisms are only active when and where intended. This enables the safe release of engineered organisms [...]
Paul Freemont, co-founder and co-director of SynbiCITE Professor Paul Freemont is co-founder of the Centre for Synthetic Biology at Imperial College London and co-founder and co-director of the UK’s National Innovation and Knowledge Centre for Synthetic Biology (SynbiCITE) which has spearheaded the commercialization of synthetic biology in the UK. His research interests [...]
Bethan Wolfenden, Co-founder of Bento Lab Bethan Wolfenden is Co-Founder of Bento Bio, aiming to do for biotechnology what Raspberry Pi and Arduino have done for electronics and computing – making it accessible and affordable to all. She is one of the creators of Bento Lab, the world’s first easy-to-use laptop-sized DNA [...]
Drew Titmarsh, Founder and CEO of Scaled Biolabs Drew Titmarsh is the CEO and co-founder of Scaled Biolabs (www.scaledbiolabs.com), a company accelerating cell therapies for regenerative medicine and cancer immunotherapy. A multidisciplinary bioengineer, Drew helped develop Scaled's core technology: a miniaturized cell culture lab which runs ~10,000 experiments in parallel, combined with automation and [...]
John Nicols, CEO of Codexis In June of 2012, John Nicols was named as the company’s second President and Chief Executive Officer. Prior to Codexis, he served for more than 22 years in various capacities at Albemarle Corporation, a public company focused on the development, manufacture, and marketing of highly engineered specialty [...]
Troy Lionberger, Senior Manager of Technology Development at Berkeley Lights. Troy Lionberger is the Senior Manager of Technology Development at Berkeley Lights, an Emeryville startup that has created the Beacon platform, a high-throughput, fully automated, microscopy system that uses light to move single cells and leverages the unique properties of a microfluidic [...]
